Chondrosarcoma

Incidence and onset information

Researches and researchers

Doctors, researchs, and experts related to Chondrosarcoma extracted from public data.

Chondrosarcoma Experts map

Current Researchs and researchers

• CAEN — Dr Catherine BAUGÉ

  Investigator of research project
  
  

  • Institution/s:
    — Faculté de médecine de Caen
  • Research area/topic::
    

    Chondrosarcoma: physiopathology and therapy



• VILLEURBANNE — Pr Marc JANIER

  Investigator of research project
  
  

  • Institution/s:
    — Université Claude Bernard Lyon 1
  • Research area/topic::
    

    RADiosensitizing nanoparticules for therapy against CHONDrosarcoma. A preclinical proof of concept.



• ERLANGEN — Dr Thorsten LANGER

  Investigator of research project
  
  

  • Institution/s:
    — Kinder- und Jugendklinik des Universitätsklinikums Erlangen
  • Research area/topic::
    

    Late Effects Surveillance System (LESS) for oncological diseases in children und adolescents



• STUTTGART — Pr Stefan S. BIELACK

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project
  
  

  • Institution/s:
    — Zentrum für Kinder- und Jugendmedizin, Klinikum Stuttgart - Standort Olgahospital
    — Pädiatrie 5 - Onkologie, Hämatologie, Immunologie, Rheumatologie, Gastroenterologie und Allgemeine Pädiatrie, Klinikum Stuttgart - Standort Olgahospital
  • Research area/topic::
    

    COSS-Register: Clinical Registry for children, adolescents and adults with Osteosarcoma and Bone Tumors



• BOLOGNA — Dr Piero PICCI

  Coordinator of expert centre - Investigator of research project - Coordinator of research network
  
  

  • Institution/s:
    — Dipartimento Patologie Ortopediche-Traumatologiche Specialistiche, Istituto Ortopedico Rizzoli - Centro di Ricerca e Poliambulatorio
  • Research area/topic::
    

    Research group of the Italian Sarcoma Group



• LEIDEN — Pr J.V.M.G. [Judith] BOVÉE

  Clinical expert - Investigator of research project
  
  

  • Institution/s:
    — LUMC - Leids Universitair Medisch Centrum
    — LUMC - Leids Universitair Medisch Centrum
  • Research area/topic::
    

    Epigenetic changes caused by IDH mutation as a target for novel anticancer therapy

Chondrosarcoma Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Hereditary Multiple Osteochrondomas-HMO. By Genetics Laboratory Shodair Children's Hospital (United States). EXT1 Specificity 100 % Genes 100 %
EXT1 Deletion/duplication analysis. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). EXT1 Specificity 100 % Genes 100 %
EXT1 Sequencing. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). EXT1 Specificity 100 % Genes 100 %
EXT1. By Department of Medical Genetics - Wuyts Lab Antwerp University Hospital (Belgium). EXT1 Specificity 100 % Genes 100 %
EXT1. MLPA testing. By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain). EXT1 Specificity 100 % Genes 100 %
EXT1. Complete sequencing. By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain). EXT1 Specificity 100 % Genes 100 %
CHOP Comprehensive Hereditary Cancer Panel. By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States). RMRP, RUNX1, BLM, SDHA, SDHB, SDHC, SDHD, BMPR1A, SH2D1A, SLC25A13, BRCA1, BRCA2, SMARCA4, SMARCB1, SMARCE1, BUB1B, EPCAM, XPA, IKZF1, CBL , (...) View the complete list with 85 more genes Panel complete gene list RMRP, RUNX1, BLM, SDHA, SDHB, SDHC, SDHD, BMPR1A, SH2D1A, SLC25A13, BRCA1, BRCA2, SMARCA4, SMARCB1, SMARCE1, BUB1B, EPCAM, XPA, IKZF1, CBL, CDC73, HAX1, DICER1, ARID5B, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CEBPA, CEBPE, DDX41, DOCK8, SBDS, BRIP1, RHBDF2, COL7A1, G6PC3, CYLD, SDHAF2, PALB2, DDB2, FLCN, DIS3L2, DKC1, EGFR, ELANE, ERCC2, ERCC3, ERCC4, ERCC5, ETV6, EXT1, EXT2, FAH, FANCA, FANCC, FANCG, FH, GATA2, GBA, ABCB11, ALK, GJB2, GPC3, HFE, HMBS, HRAS, APC, ITK, KIT, SMAD4, MAX, MEN1, MET, MLH1, MPL, MSH2, MSH6, MTAP, MUTYH, NBN, NF1, NF2, ATM, PAX5, PDGFRA, SERPINA1, AXIN2, PMS2, PHOX2B, POLD1, POLE, POLH, PRKAR1A, PRSS1, BAP1, PTCH1, PTEN, PTPN11, RAD51C, RAD51D, RB1, RECQL4, RET Close Specificity 1 % Genes 100 %
Trichorhinophalangeal Syndrome Type II [Langer-Giedion Syndrome]. By CGC Genetics (Portugal). TRPS1, EXT1 Specificity 50 % Genes 100 %

Sources and references

You can check the following sources for additional information.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME ZTTK SYNDROME; ZTTKS STICKLER SYNDROME, TYPE I; STL1 ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP BLAU SYNDROME PROSTATE CANCER